| 发明名称 | Therapeutic approaches for treating Alzheimer's disease | ||
| 摘要 | The present invention relates to compositions and methods for the treatment of Alzheimer's disease and related disorders. More specifically, the present invention relates to novel combinatorial therapies of Alzheimer's disease and related disorders. In particular, the invention concerns compounds which, alone or in combination(s), can effectively modulate synapse function and/or angiogenesis and/or cell stress response. The invention also relates to methods of producing a drug or a drug combination for treating Alzheimer's disease and to methods of treating Alzheimer's disease or a related disorder. | ||
| 申请公布号 | US9387206(B2) | 申请公布日期 | 2016.07.12 |
| 申请号 | US201414461849 | 申请日期 | 2014.08.18 |
| 申请人 | PHARNEXT | 发明人 | Cohen Daniel;Chumakov Ilya;Nabirochkin Serguei |
| 分类号 | A61K31/495;A61K31/16;A61K45/06;A61K31/137;A61K31/185;A61K31/195;A61K31/343;A61K31/423;A61K31/197;A61K31/50;A61K31/64 | 主分类号 | A61K31/495 |
| 代理机构 | Saliwanchik, Lloyd & Eisenschenk | 代理人 | Saliwanchik, Lloyd & Eisenschenk |
| 主权项 | 1. A method of treating Alzheimer's disease (AD) or an AD related disorder in a human in need thereof, the method comprising administering, per day, between 30 μg and 400 mg of carbamazine or a salt thereof or a sustained release formulation thereof to said human. | ||
| 地址 | Issy les Moulineaux FR | ||